InsiderClue
← All stocks

FENNEC PHARMACEUTICALS INC.

FENC Net selling
CIK 0001211583 #3277 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$1.31M
$1.00M on a plan · $159.96K straight out of an exercise
Sold at will
$146.16K
1 of 4 sales
Net
−$1.31M
−$146.16K against sales at will

By person

9 insiders · 5 transactions
1.1×

Jeffrey Hackman holds only 1.1 times base salary in stock. $682.25K of shares against $586.34K in salary for 2025.

Salary from the company's own proxy. The shares are what Jeffrey Hackman last reported holding, valued at $10.29, the price Common Shares was last bought or sold at on the open market here, on 15 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Andrade Robert
CHIEF FINANCIAL OFFICER
—
$883.50K (1) scheduled
−$883.50K
241,306
0.6881%
$2.48M
+120.4%
Brughera Marco Maria
Director
—
$159.96K (1) scheduled
−$159.96K
0
0.0000%
$0.00
—
Sayad Pierre Sargis
Chief Medical Officer
—
$146.16K (1)
−$146.16K
9,519
0.0271%
$97.95K
—
Raykov Rosty
Former Director
—
$121.10K (1) scheduled
−$121.10K
124,411
0.3548%
$1.28M
+103.2%
Southpoint Capital Advisors LP entity
10% owner
—
—
—
2,744,741
7.83%
$28.24M
−32.7%
Hackman Jeffrey S.
Chief Executive Officer
—
—
—
66,302
0.1891%
$682.25K
—
RALLIS CHRIS A
Director
—
—
—
63,077
0.1799%
$649.06K
+31.2%
Cioffi Christiana Marie
Chief Strategy Officer
—
—
—
24,644
0.0703%
$253.59K
—
Evans Terry L
Chief Commercial Officer
—
—
—
21,519
0.0614%
$221.43K
—

Individual transactions

1
Insider
Date
Role
Action
Shares
Price
Amount
Sayad Pierre Sargis
31 Aug 2026
Chief Medical Officer
Sell
12,000
$12.18
$146.16K
Show all 5 transactions →

What was left out

Form 4 filings counted 8
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 1
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 43,605
History held since 14 Dec 2017